ConductScience.org, home

Paper4600629

The antagonism of amphetamine-induced symptomatology by a neuroleptic.

Angrist B and 2 others. Am J Psychiatry, 1974. Cited by 98 papers, by iCite.

Cite this record

ConductScience Library. The antagonism of amphetamine-induced symptomatology by a neuroleptic. Papers, record 4600629. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4600629

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The antagonism of amphetamine-induced symptomatology by a neuroleptic.
PubMed
Journal
Am J Psychiatry
PubMed
Year
1974
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
98
iCite
Relative citation ratio, by iCite
4.24
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Angrist BB
2Lee HKH K
3Gershon SS

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmphetamineMajor topic
Dopamine AntagonistsMajor topic
HaloperidolMajor topic
Psychoses, Substance-InducedMajor topic
Brain Chemistry
Clinical Trials as Topic
Dopamine
Dose-Response Relationship, Drug
Drug Antagonism
Drug Evaluation
Humans
Psychiatric Status Rating Scales
Substance-Related Disorders

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.

PMIDTitleJournalYearIn PapersSource
29572651Diazepam blocks 50 kHz ultrasonic vocalizations and stereotypies but not the increase in locomotor activity induced in rats by amphetamine.Psychopharmacology (Berl)2018https://conductscience.org/library/papers/29572651PubMed
23688691Neurologic manifestations of chronic methamphetamine abuse.Psychiatr Clin North Am2013https://conductscience.org/library/papers/23688691PubMed
21803215Neurologic manifestations of chronic methamphetamine abuse.Neurol Clin2011https://conductscience.org/library/papers/21803215PubMed
20919312The role of dopamine in the antipsychotic effect and the pathogenesis of schizophrenia.Proc R Soc Med1977https://conductscience.org/library/papers/20919312PubMed
19609589Cannabis and psychosis/schizophrenia: human studies.Eur Arch Psychiatry Clin Neurosci2009https://conductscience.org/library/papers/19609589PubMed
19160215Treatment for amphetamine psychosis.Cochrane Database Syst Rev2009https://conductscience.org/library/papers/19160215PubMed
18228005Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.Psychopharmacology (Berl)2008https://conductscience.org/library/papers/18228005PubMed
17078926G protein-coupled receptors in major psychiatric disorders.Biochim Biophys Acta2007https://conductscience.org/library/papers/17078926PubMed
15495131Amphetamines for schizophrenia.Cochrane Database Syst Rev2004https://conductscience.org/library/papers/15495131PubMed
12589522Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma.Psychopharmacology (Berl)2003https://conductscience.org/library/papers/12589522PubMed
11394190Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?J Psychiatry Neurosci2001https://conductscience.org/library/papers/11394190PubMed
8741951Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects.Psychopharmacology (Berl)1996https://conductscience.org/library/papers/8741951PubMed
7669701Consciousness: a neurobiological approach.Integr Physiol Behav Sci1995https://conductscience.org/library/papers/7669701PubMed
6123132Disruption of primate social behavior by d-amphetamine and cocaine: differential antagonism by antipsychotics.Psychopharmacology (Berl)1982https://conductscience.org/library/papers/6123132PubMed
6102776Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6102776PubMed
2498964Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization.Psychopharmacology (Berl)1989https://conductscience.org/library/papers/2498964PubMed
826971Serum dopamine-beta-hydroxylase in psychiatric patients and normals. Effect of d-amphetamine and haloperidol.Psychopharmacology (Berl)1976https://conductscience.org/library/papers/826971PubMed
116271Social isolation and other behavioral changes in groups of adult vervet monkeys (Cercopithecus aethiops) produced by low, nonchronic doses of d-amphetamine.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/116271PubMed
113814Dopaminergic mechanisms and cognitive deficit in schizophrenia. A neurobiological model.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/113814PubMed
28546Neuroleptic interference with the cocaine cue: internal stimulus control of behavior and psychosis.Psychopharmacology (Berl)1978https://conductscience.org/library/papers/28546PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4600629

GET https://conductscience.org/api/papers/v1/4600629/authors